SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-334595
Filing Date
2021-11-19
Accepted
2021-11-19 08:44:31
Documents
7
Effectiveness Date
2021-11-19

Document Format Files

Seq Description Document Type Size
1 S-8 d232380ds8.htm S-8 90117
2 EX-5.1 d232380dex51.htm EX-5.1 12623
3 EX-23.1 d232380dex231.htm EX-23.1 1693
4 EX-99.8 d232380dex998.htm EX-99.8 101227
5 EX-99.9 d232380dex999.htm EX-99.9 83530
6 GRAPHIC g232380dsp2a.jpg GRAPHIC 1748
7 GRAPHIC g232380g1117235909510.jpg GRAPHIC 2376
  Complete submission text file 0001193125-21-334595.txt   296426
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-261205 | Film No.: 211426460
SIC: 2836 Biological Products, (No Diagnostic Substances)